These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up. Jonas S; Neuhaus R; Junge G; Klupp J; Theruvat T; Langrehr JM; Settmacher U; Neuhaus P Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470 [TBL] [Abstract][Full Text] [Related]
26. Renal allograft function and histology in children on triple immunosuppression based on individual pharmacokinetically determined cyclosporine administration. Laine J; Hoppu K; Holmberg C Transplant Proc; 1994 Oct; 26(5):2775-6. PubMed ID: 7940874 [No Abstract] [Full Text] [Related]
27. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M; Latter DA; Loertscher R Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [TBL] [Abstract][Full Text] [Related]
28. [Adverse effects of immunosuppression following kidney allotransplantation and data on the mechanism of infectious complications]. Tomilina NA; L'vitsina GM Vestn Akad Med Nauk SSSR; 1973; 28(8):64-6. PubMed ID: 4585256 [No Abstract] [Full Text] [Related]
29. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients. Câmara NO; Dias MF; Pacheco-Silva A Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825 [TBL] [Abstract][Full Text] [Related]
30. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants. Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332 [TBL] [Abstract][Full Text] [Related]
31. Methotrexate for rejection prophylaxis after heart transplantation. Taylor DO; Olsen SL; Ensley RD; Renlund DG J Heart Lung Transplant; 1995; 14(5):950-4. PubMed ID: 8800732 [TBL] [Abstract][Full Text] [Related]
37. Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes. Boratynska M; Banasik M; Patrzalek D; Klinger M Exp Clin Transplant; 2008 Mar; 6(1):59-66. PubMed ID: 18405247 [TBL] [Abstract][Full Text] [Related]
38. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]
39. Renal homotransplantation in infants and children with the hemolytic-uremic syndrome. Cerilli GJ; Nelsen C; Dorfmann L Surgery; 1972 Jan; 71(1):66-71. PubMed ID: 4550237 [No Abstract] [Full Text] [Related]
40. Immunosuppressive regimens and their effects on renal allograft outcome. Katznelson S; Cecka JM Clin Transpl; 1996; ():361-71. PubMed ID: 9286582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]